ivan_gold_star_

📉Record unemployment in the US -an opportunity to earn IPO ACCD

Long
FRED:UNRATE   Civilian Unemployment Rate
🔎 Hello everyone! We have an interesting trading idea for you - how you can earn 50% or more on the exchange by participating in the initial placement of Accolade shares (ACCD). Accolade is a startup that has developed a healthcare platform for employers. The company's platform helps its users better navigate the healthcare system, as well as reduce costs for medical purposes. As you know, due to COVID-19, many companies now suffer huge costs and strive to optimize their performance as best as possible. By the way, unemployment in the US is now at a record level, which has not been recorded since the great depression (1929-1939) - see the chart.

ACC Accolade uses a range of technologies - from machine learning to mobile apps-to make it easier for employees to access medical care. Employers are charged a subscription fee depending on the number of employees. The volume of investments attracted by the company, according to crunchabase, amounts to $237.3 million. In addition, Accolade has bought the company and konciergeMD MD Insider. You can see the picture of the business structure of this company below.

🤝 If you need statistics on the company's financial performance, you can write to me and I will send you a detailed report. If you do not know how to perform the operation and start from 25,000 rubles, you can also write to me, I will help you, but the deadline is 20-00 today in Moscow. Opportunities appear quickly and disappear just as quickly. I expect the return on this IPO to be around + 50% or higher, but I remind you that there is a risk of losing all or part of your capital, so invest no more than what you are prepared to lose.

📈 Graphs will be in the comments, so that the article is not blocked
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.